January 12, 2026
Eikon Therapeutics Files for IPO Amid Biotech Rally Test
Eikon Therapeutics; IPO filing; biotech rally; cancer drugs; Nasdaq EIKN
AbbVie Pays $650M Upfront to RemeGen for PD-1/VEGF Bispecific RC148 Rights Outside China
AbbVie; RemeGen; RC148; PD-1/VEGF; bispecific antibody; oncology; licensing deal; $650M; $5.6B
BioNTech and UPenn Launch $50M Seed Fund for Early-Stage Biotechs
BioNTech; UPenn; seed fund; $50M; mRNA; biotech startups
CRISPR Pioneers Jennifer Doudna and Fyodor Urnov Launch Aurora Therapeutics for Custom CRISPR Therapies
Aurora Therapeutics; CRISPR; gene editing; personalized therapies; Jennifer Doudna; Fyodor Urnov; rare diseases; Menlo Ventures
Novartis Announces Fourth US Radioligand Therapy Facility in Winter Park, Florida
Novartis; radioligand therapy; Florida; Winter Park; manufacturing facility; cancer treatment
Veradermics Files for $100 Million IPO to Advance Oral Minoxidil Hair Loss Treatment
Veradermics; IPO; hair loss; minoxidil; VDPHL01; Phase 3
Kinaset Therapeutics Raises $103M to Advance Inhaled Asthma Drug
Kinaset Therapeutics; funding; asthma drug; inhaled therapy; Series A
Pulse Biosciences, Inc. Appoints Maria Sainz to Board of Directors Effective January 9, 2026
Pulse Biosciences; Maria Sainz; Board Appointment; nPulse; Healthcare Technology; Medtech
Abivax Stock Surges on Reports of $17.5 Billion Eli Lilly Takeover Interest
Abivax; ABVX; Eli Lilly; takeover bid; stock surge; obefazimod